STOCK TITAN

SPAR Group exchanges $4M owed for preferred shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

SPAR Group, Inc. (SGRP) 10% owner ReposiTrak, Inc. entered into an exchange transaction with SPAR on November 13, 2026. ReposiTrak exchanged $4.0 million of outstanding principal and accrued interest owed to it for 4,000 Series C Preferred shares, and exchanged 8,900,406 common shares for 3,360 Series C Preferred shares. It acquired a warrant to purchase 9,684,211 common shares; the reported common-stock position after the exchange was zero.

The transaction resulted in 7,360 Series C Preferred shares, convertible into 19,368,421 common shares, and the warrant. The reported conversion/exercise price was $0.38. The preferred shares are immediately exercisable and do not expire; the warrant is exercisable beginning January 31, 2028, and expires January 31, 2032. Both instruments are subject to a 50% beneficial-ownership limitation that expires December 23, 2027. The transaction was not reported as made under a Rule 10b5-1 plan.

Insider ReposiTrak, Inc.
Role 10% Owner
Type Security Shares Price Value
Other Series C Preferred Stock F1, F2, F3 7,360 -- --
Other Warrant F1, F3 9,684,211 -- --
Other Common Stock F1 8,900,406 -- --
Holdings After Transaction: Series C Preferred Stock — 7,360 shares (Direct); Warrant — 9,684,211 warrants (Direct); Common Stock — 0 shares (Direct)
Footnotes (3)
  1. F1. The Reporting Owner entered into an exchange transaction with the Issuer pursuant to an agreement dated November 13, 2026 whereby (i) $4.0 million of outstanding principal and accrued interest owed to the Reporting Owner was exchanged for 4,000 shares of the Issuer's Series C Convertible Preferred Stock ("Series C Preferred"); (iii) 8,900,406 shares of the Issuer's common stock held by the Reporting Owner was exchanged for 3,360 shares of Series C Preferred; (iv) the Issuer issued the Company a warrant to purchase an aggregate of 9,684,211 shares of common stock (the "Warrant"). The transaction was approved by the Board of Directors of each of the Reporting Owner and the Issuer and is exempt pursuant to Rules 16b-3 (d) and (e) of the Securities Exchange Act of 1934, as amended.
  2. F2. The Series C Preferred is exercisable immediately and does not expire.
  3. F3. The Series C Preferred and Warrants are subject to beneficial ownership limitations whereby they shall not be exercisable, and the Series C Preferred cannot be converted, to the extent their exercise or conversion, as the case may be, would cause the beneficial ownership of Common Stock held by the Reporting Owner to exceed 50% of the total issued and outstanding shares of Common Stock of the Issuer ("Beneficial Ownership Limitation"), which Beneficial Ownership Limitation expires on December 23, 2027.
Outstanding principal and accrued interest exchanged $4.0 million Exchanged for 4,000 Series C Preferred shares on November 13, 2026.
Common shares exchanged 8,900,406 shares Exchanged for 3,360 Series C Preferred shares on November 13, 2026.
Series C Preferred shares acquired 7,360 shares Total reported preferred shares after the exchange.
Common shares underlying preferred shares 19,368,421 shares Underlying shares reported for the Series C Preferred.
Common shares underlying warrant 9,684,211 shares Shares the warrant permits the holder to purchase.
Conversion/exercise price $0.38 Reported for the Series C Preferred and warrant.
Beneficial-ownership limitation 50% Applies to conversion or exercise; expires December 23, 2027.
Common shares following transaction 0 shares ReposiTrak's reported common-stock position after the exchange.
Series C Convertible Preferred Stock financial
"4,000 shares of the Issuer's Series C Convertible Preferred Stock"
Series C convertible preferred stock is a class of investment shares issued in a later private financing round that combine safety and upside: they usually pay ahead of ordinary shares if a company pays dividends or is sold, but can be converted into common stock to share in future growth. For investors this acts like a VIP ticket with a safety net—offering priority protection while preserving the option to participate in a successful exit.
Beneficial Ownership Limitation regulatory
"the "Beneficial Ownership Limitation" expires on December 23, 2027"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Rules 16b-3 (d) and (e) regulatory
"exempt pursuant to Rules 16b-3 (d) and (e)"
accrued interest financial
"$4.0 million of outstanding principal and accrued interest"
Accrued interest is the amount of interest that has built up on a loan, bond, or similar investment since the last payment date but has not yet been paid. For investors this matters because when you buy or sell a fixed‑income security between payment dates you compensate the other party for that earned interest—think of it like buying a house mid‑month and reimbursing the seller for days of heating already used—so it affects the actual cash you pay, the yield you receive, and short‑term returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ReposiTrak exchange with SGRP on November 13, 2026?

ReposiTrak exchanged $4.0 million of outstanding principal and accrued interest owed to it for 4,000 Series C Preferred shares, and exchanged 8,900,406 common shares for 3,360 Series C Preferred shares. It also acquired a warrant to purchase 9,684,211 common shares. The transaction was not reported as made under a Rule 10b5-1 plan.

When can the SGRP Series C Preferred shares and warrant be exercised?

The Series C Preferred shares are immediately exercisable and do not expire. The warrant is exercisable beginning January 31, 2028, and expires January 31, 2032.

What ownership limit applies to ReposiTrak's SGRP preferred shares and warrant?

Conversion of the preferred shares and exercise of the warrant are restricted to the extent they would cause ReposiTrak's beneficial ownership to exceed 50% of SPAR's issued and outstanding common stock. The limitation expires December 23, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ReposiTrak, Inc.

(Last)(First)(Middle)
5282 SOUTH COMMERCE DRIVE
SUITE D292

(Street)
MURRAY UTAH 84107

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SPAR Group, Inc. [ SGRP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/13/2026J(1)8,900,406D(1)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series C Preferred Stock$0.3811/13/2026J(1)7,360 (2) (2)Common Stock19,368,421(3)(1)7,360D
Warrant$0.3811/13/2026J(1)9,684,21101/31/202801/31/2032Common Stock9,684,211(3)(1)9,684,211D
Explanation of Responses:
1. The Reporting Owner entered into an exchange transaction with the Issuer pursuant to an agreement dated November 13, 2026 whereby (i) $4.0 million of outstanding principal and accrued interest owed to the Reporting Owner was exchanged for 4,000 shares of the Issuer's Series C Convertible Preferred Stock ("Series C Preferred"); (iii) 8,900,406 shares of the Issuer's common stock held by the Reporting Owner was exchanged for 3,360 shares of Series C Preferred; (iv) the Issuer issued the Company a warrant to purchase an aggregate of 9,684,211 shares of common stock (the "Warrant"). The transaction was approved by the Board of Directors of each of the Reporting Owner and the Issuer and is exempt pursuant to Rules 16b-3 (d) and (e) of the Securities Exchange Act of 1934, as amended.
2. The Series C Preferred is exercisable immediately and does not expire.
3. The Series C Preferred and Warrants are subject to beneficial ownership limitations whereby they shall not be exercisable, and the Series C Preferred cannot be converted, to the extent their exercise or conversion, as the case may be, would cause the beneficial ownership of Common Stock held by the Reporting Owner to exceed 50% of the total issued and outstanding shares of Common Stock of the Issuer ("Beneficial Ownership Limitation"), which Beneficial Ownership Limitation expires on December 23, 2027.
/s/ John Merrill Title: Chief Financial Officer11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading